Judge Approves $7.25 Billion Settlement With Bayer Over Roundup Cancer Cases

By Aldgra Fredly
Aldgra Fredly
Aldgra Fredly
Aldgra Fredly is a freelance writer covering U.S. and Asia Pacific news for The Epoch Times.
November 21, 2026Updated: November 21, 2026

A Missouri judge on Nov. 20 approved a proposed $7.25 billion nationwide settlement with Germany-based agrochemical giant Bayer over lawsuits alleging that its weed killer Roundup causes lymphoma, a cancer of the lymphatic system.

In an 84-page ruling, Missouri Circuit Judge Timothy Boyer in St. Louis found that the settlement agreement was “fair, reasonable, and adequate,” saying that it served “the best interests” of the class representatives and all settlement class members.

The judge said the settlement requires Bayer, which acquired Roundup from U.S. manufacturer Monsanto in 2018, to pay the compensation over 17 to 21 years to resolve current and future lawsuits brought by people alleging that Roundup caused them to develop non-Hodgkin lymphoma.

In a statement, Bayer CEO Bill Anderson called the court’s final approval of the settlement agreement “a decisive milestone” in the company’s strategy to mitigate the risks of both pending and future Roundup litigation.

This article will be updated.

Trump Urges ‘Very Political’ Fed to Lower Interest Rates
RELATED
Federal Judge Allows Mamdani's City-Owned Grocery Stores to Proceed